About City of Hope - Lennar Foundation Cancer Center
"City of Hope Orange County Lennar Foundation Cancer Center will be a department of City of Hope National Medical Center, a general acute care hospital. The 190,000 square-foot cancer center will be patient-focused, offering highly specialized cancer care, clinical research with access to Phase 1-3 clinical trials, precision medicine, and early detection and prevention programs. It will be the home of leading cancer researchers and healthcare professionals and be a center for innovation and compassionate care."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at City of Hope - Lennar Foundation Cancer Center
During the past decade, City of Hope - Lennar Foundation Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "City of Hope - Lennar Foundation Cancer Center"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at City of Hope - Lennar Foundation Cancer Center
According to Clinical.Site data, the most researched conditions in "City of Hope - Lennar Foundation Cancer Center" are
"Multiple Myeloma" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "City of Hope - Lennar Foundation Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at City of Hope - Lennar Foundation Cancer Center
Most popular intervention types in "City of Hope - Lennar Foundation Cancer Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cevostamab" (1 trials), "Daratumumab" (1 trials), "Dexamethasone" (1 trials), "INCB0123667" (1 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at City of Hope - Lennar Foundation Cancer Center
The vast majority of trials in "City of Hope - Lennar Foundation Cancer Center" are
2 trials for "All" genders.
Clinical Trials Status at City of Hope - Lennar Foundation Cancer Center
Currently, there are NaN active trials in "City of Hope - Lennar Foundation Cancer Center".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in City of Hope - Lennar Foundation Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in City of Hope - Lennar Foundation Cancer Center, 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".